Pink, D., Lindner, T., Mrozek, A., Kretzschmar, A., Thuss-Patience, P.C., Dorken, B. and Peter, R. (2006) Harm or bene-fit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: Single center experience with 10 cases and review of the literature. Gynecologic Oncology, 101, 464-469. doi:10.1016/j.ygyno.2005.11.010

has been cited by the following article:

• TITLE: Endometrial stromal sarcoma presenting as multiple primary tumor

  AUTHORS: Rajiv Kumar Saxena, Gurpreet Singh Sandhu, Karimbanamalayil Madhavi Babu

  KEYWORDS: Endometrial Stromal Sarcoma; Synchronous Multiple Primary Tumour; Invasive Ductal Breast

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.3 No.1, January 21, 2013

  ABSTRACT: Endometrial Stromal Sarcoma (ESS) is a rare uterine malignancy. The annual incidence of ESS has been reported as 1 - 2 per million women. In the general population approximately 10 percent of cancer patients may develop a second primary cancer. Synchronous multiple primary tumors constitute only 20% of all multiple primary tumors, and by definition, occur within a period of two month. This case report is presented to document the occurrence of ESS as a “Synchronous Multiple Primary Tumor”, which is an extremely rare event. Previously only one case report has documented such an occurrence. The literature is also briefly reviewed. This case underlines the requirement of a thorough initial evaluation for a patient with a gynecological malignancy and a regular follow-up. Follow-up includes patient education regarding symptoms of any recurrence, physical examination repeated at 6 - 12 monthly interval, along with imaging studies when indicated.